نتایج جستجو برای: hemophilic patients

تعداد نتایج: 2085548  

Journal: :Srpski arhiv za celokupno lekarstvo 2006
Dan V Poenaru Margit Serban Ioan L Branea Jenel M Pătraşcu

INTRODUCTION Patients having severe hemophilia (levels of deficient factor below 1%) frequently suffer from disabling chronic arthropathy. An adequate substitution treatment using the coagulation factor VIII or IX concentrates renders an elective surgery feasible. OBJECTIVE The objective of the study was to check the results of different surgical procedures in the treatment of hemophilic arth...

2017
Daniela Melchiorre Mirko Manetti Marco Matucci-Cerinic

Spontaneous joint bleeding and repeated hemarthroses lead to hemophilic arthropathy-a debilitating disease with a significant negative impact on mobility and quality of life. Iron, cytokines, and angiogenic growth factors play a pivotal role in the onset of the inflammatory process that involves the synovial tissue, articular cartilage, and subchondral bone, with early damages and molecular cha...

Journal: :Revista Española de Enfermedades Digestivas 2010

Journal: :Japanese Journal of Thrombosis and Hemostasis 2017

2010
Baisong Mei Clark Pan Haiyan Jiang Hendri Tjandra Jonathan Strauss Yaoqi Chen Tongyao Liu Xin Zhang Joanne Severs Jim Newgren Jianmin Chen Jian-Ming Gu Babu Subramanyam Michael A. Fournel Glenn F. Pierce John E. Murphy

A long-acting factor VIII (FVIII) as a replacement therapy for hemophilia A would significantly improve treatment options for patients with hemophilia A. To develop a FVIII with an extended circulating half-life, but without a reduction in activity, we have engineered 23 FVIII variants with introduced surface-exposed cysteines to which a polyethylene glycol (PEG) polymer was specifically conjug...

Journal: :Blood 2011
Suchitra S Acharya Rosandra N Kaplan Dan Macdonald Oluwa T Fabiyi Donna DiMichele David Lyden

Joint arthropathy secondary to recurrent hemarthroses remains a debilitating complication of hemophilia despite the use of prophylactic factor concentrates. Increased vascularity and neoangiogenesis have been implicated in the progression of musculoskeletal disorders and tumor growth. We hypothesized that de novo blood vessel formation could play a major role in the pathogenesis of hemophilic j...

2014
S R Lentz S Ehrenforth F Abdul Karim T Matsushita K N Weldingh J Windyga J N Mahlangu For the Adept™2 Investigators

BACKGROUND Vatreptacog alfa, a recombinant factor VIIa (rFVIIa) analog with three amino acid substitutions and 99% identity to native FVIIa, was developed to improve the treatment of hemophilic patients with inhibitors. OBJECTIVES To confirm the safety and assess the efficacy of vatreptacog alfa in treating bleeding episodes in hemophilic patients with inhibitors. PATIENTS AND METHODS In th...

Journal: :Haematologica 2005
Francesco Dragoni Giuseppe Gentile Claudio Cartoni Flavia Chiarotti Maria Puopolo Maria Gabriella Mazzucconi Luigi Maria De Matteis Maria Pirillo Pietro Martino

BACKGROUND AND OBJECTIVES Endoscopic procedures are the gold standard for the diagnosis of esophageal varices but these invasive methods are complex to perform in hemophilic patients co-infected with hepatitis C virus/human immunodeficiency virus (HCV/HIV). Real-time ultrasonography has been reported to be an effective, non-invasive procedure able to monitor patients with chronic liver disease ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید